UBS AM
AVIR icon

UBS AM’s Atea Pharmaceuticals AVIR Stock Holding History

UBS AM’s Portfolio AVIR Stock Details AVIR Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.5K Buy
2023
Q3 		– Sell
2023
Q2 		$302K Hold
2023
Q1 		$302K Hold
2022
Q4 		$433K Buy
2022
Q3 		$498K Sell
2022
Q2 		$721K Buy
2022
Q1 		$117K Hold
2021
Q4 		$144K Buy
2021
Q3 		$443K Buy